Search Within

Martin Stuart Tallman

  1. "2018"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (29)
  3. Book Section (2)
Groups
  1. Adult Leukemia (63)
  2. Center for Hematologic Malignancies (63)
  3. Department of Medicine (63)
  4. Hematologic Malignancies, Division of (63)
  5. Weinberg Fellows (19)
  6. GSK Faculty (15)

More Groups

People
  1. Eytan Stein (14)
  2. Ross Levine (11)
  3. Aaron Goldberg (9)
  4. Christopher Famulare (9)
  5. Jae Park (9)
  6. Sean Devlin (8)

More People

Years
  1. 2018 (63)
Publications
  1. Blood (31)
  2. Blood Advances (5)
  3. Leukemia Research (4)
  4. Biology of Blood and Marrow Transplantation (3)
  5. American Journal of Hematology (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Hematology (36)
  2. Elsevier Inc. (4)
  3. Elsevier Ltd (4)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (63)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma
    Meeting Abstract

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: A continued, complicated conversation
    Journal Article

    Menghrajani, K. N.; Tallman, M. S.
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance)
    Journal Article

    Byrd, J. C.; Ruppert, A. S.; Heerema, N. A.; Halvorson, A. E.; Hoke, E.; Smith, M. R.; Godwin, J. E.; Couban, S.; Fehniger, T. A.; Thirman, M. J.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Aberrant GSK3β nuclear localization promotes AML growth and drug resistance
    Journal Article

    Ignatz-Hoover, J. J.; Wang, V.; Mackowski, N. M.; Roe, A. J.; Ghansah, I. K.; Ueda, M.; Lazarus, H. M.; de Lima, M.; Paietta, E.; Fernandez, H.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
    Journal Article

    Kunimoto, H.; Meydan, C.; Nazir, A.; Whitfield, J.; Shank, K.; Rapaport, F.; Maher, R.; Pronier, E.; Meyer, S. C.; Garrett-Bakelman, F. E.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Ivosidenib (AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia: Results of a phase 1 study
    Meeting Abstract

    DiNardo, C. D.; Stein, E. M.; de Botton, S.; Roboz, G. J.; Altman, J. K.; Mims, A. S.; Swords, R.; Collins, R. H.; Mannis, G. N.; Pollyea, D. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Time to repeal and replace response criteria for acute myeloid leukemia?
    Journal Article

    Bloomfield, C. D.; Estey, E.; Pleyer, L.; Schuh, A. C.; Stein, E. M.; Tallman, M. S.; Wei, A.
    Blood Reviews (2018)

    Fulltext@MSK | Save
  • Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study
    Journal Article

    Epstein, D. J.; Seo, S. K.; Huang, Y. T.; Park, J. H.; Klimek, V. M.; Berman, E.; Tallman, M. S.; Frattini, M. G.; Papanicolaou, G. A.
    Journal of Infection (2018)

    Fulltext@MSK | Save
  • Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
    Journal Article

    Ganzel, C.; Sun, Z.; Cripe, L. D.; Fernandez, H. F.; Douer, D.; Rowe, J. M.; Paietta, E. M.; Ketterling, R.; O'Connell, M. J.; Wiernik, P. H.; more...
    American Journal of Hematology (2018)

    Fulltext@MSK | Save